COMMUNIQUÉS West-GlobeNewswire

Hoth Therapeutics Inc. Announces Closing of Initial Public Offering

20/02/2019 - 22:30

NEW YORK, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Hoth Therapeutics Inc. (“Hoth” or the “Company”), a development stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications [...]

Profound Medical to Participate in the 2019 BTIG MedTech, Life Science & Diagnostic Tools Conference

20/02/2019 - 22:30

TORONTO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that combines real-time Magnetic Resonance (“MR [...]

Sarepta Therapeutics to Announce Limb-Girdle Muscular Dystrophy Type 2E Data Results and Fourth Quarter and Full-Year 2018 Financial Results and Recent Corporate Developments on February 27, 2019

20/02/2019 - 22:30

CAMBRIDGE, Mass., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, announced that commencing at 8:00 a.m. Eastern Time (ET) on [...]

T2 Biosystems Announces 2018 Fourth Quarter and Full Year Financial and Operational Results Release and Conference Call Date

20/02/2019 - 22:30

LEXINGTON, Mass., Feb. 20, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, [...]

Intercept to Announce Fourth Quarter and Full Year 2018 Financial Results on February 28, 2019

20/02/2019 - 22:30

NEW YORK, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]

Inovalon Reports Fourth Quarter and Full Year 2018 Results

20/02/2019 - 22:15

Full Year 2018 Highlights Full year revenue of $527.7 million, up 17% year-over-year Full year net loss of $39.2 million, resulting in net loss of $0.27 per share Full year Non-GAAP net income of $39.3 million, [...]

Cutera Appoints Katherine Zanotti and Joseph Whitters to its Board of Directors

20/02/2019 - 22:06

BRISBANE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- CUTERA, INC., (Nasdaq: CUTR ) (“Cutera” or the “Company”) a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, [...]

Cutera Reports Fourth Quarter and Full Year 2018 Financial Results

20/02/2019 - 22:05

Total truSculpt® Body Sculpting Generated 32% Revenue Growth in 2018 BRISBANE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Cutera, Inc. (NASDAQ: CUTR ) (“Cutera” or the “Company”), a leading provider of laser and other [...]

Achaogen Announces Closing of $15 Million Underwritten Public Offering

20/02/2019 - 22:02

SOUTH SAN FRANCISCO, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc. (Nasdaq:AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug [...]

HTG Molecular Announces an Amendment and Extension to its Precision Diagnostic Partnership (PDP) Two

20/02/2019 - 22:01

TUCSON, Ariz., Feb. 20, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it has amended its second [...]

Achaogen Announces Presentations at Two Upcoming Investor Healthcare Conferences

20/02/2019 - 22:01

-- Leerink February 27, 2019 at 9:30 a.m. ET -- -- Cowen March 12, 2019 at 12:00 p.m. ET -- SOUTH SAN FRANCISCO, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company [...]

ReWalk Robotics Announces Proposed Public Offering of Ordinary Shares

20/02/2019 - 22:01

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Feb. 20, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ ReWalk ” or the “ Company ”) today announced that it intends to offer and sell, subject to market and [...]

Eloxx Pharmaceuticals to Present at the Barclays Global Healthcare Conference on March 14, 2019

20/02/2019 - 22:00

WALTHAM, Mass., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic [...]

Gritstone Oncology to Present at Leerink Partners Annual Global Healthcare Conference

20/02/2019 - 22:00

EMERYVILLE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, [...]

Axiom Real-Time Metrics Awarded Multiple IWRS/RTSM Studies Using Fusion’s IWRS Module

20/02/2019 - 18:28

TORONTO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics, premier provider of unified eClinical solutions and services, has been awarded three new studies using its powerful Fusion eClinical Suite’s IWRS [...]

PCI Biotech: Exercise of employee share options, mandatory notification of trade and resolution to increase share capital

20/02/2019 - 18:17

Oslo (Norway), 20 February 2019 – Exercise of employee share options, mandatory notification of trade and resolution to increase the share capital in PCI Biotech Holding ASA (the “Company”). 1. Options exercised and [...]

Fast Company Names T2Biosystems One of the World’s Most Innovative Companies – For Battling Sepsis in Hours not Days

20/02/2019 - 18:00

Company ranked among Top Ten Most Innovative Companies in Biotech on annual list of organizations transforming industries and shaping society LEXINGTON, Mass., Feb. 20, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. ( [...]

Marrone Bio Innovations Appoints Zachary Moye as Southeastern U.S. Territory Sales Manager

20/02/2019 - 18:00

DAVIS, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (MBI) (NASDAQ: MBII), a leading global provider of bio-based pest management and plant health products, today announced that Zack Moye has [...]

Genmab 2018 Annual Report

20/02/2019 - 17:18

Company Announcement Copenhagen, Denmark; February 20, 2019 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today its Annual Report for 2018. Below is a summary of business progress and financial performance for the [...]